ELIPSE are getting close to the next recruitment milestone of 650 participants! Thank you everyone and please keep it up! @Krish_Narahari, @jonathananing, @Heer_Lab, @vishhanchanale, @benchallacombe, @BURSTurology

We are delighted to welcome Angela Ballantyne. Professor of Bioethics at the University of Otago in Wellington. Looking forward to discussing all sorts of ethical issues around different trial designs, trial funding, data use and AI!!

New international study looking at ways to make clinical trials more informative now published - led by our Sarah Prowse and Shaun Treweek. It draws on insights from interviews with 55 stakeholders from 16 countries. @streweek.bsky.social See jamanetwork.com/journals/jam...

International Stakeholder Guidance for Improving Randomized Clinical Trials

This qualitative study uses semistructured interviews with key stakeholders involved in funding, design, sponsorship, and ethical or regulatory overview of randomized clinical trials to guide potentia...

jamanetwork.com

How well do prevailing ideas about healthcare quality and improvement serve efforts to make services better? Consider reading the new book from Alan Cribb, Polly Mitchell and our Vikki Entwistle (published today, incl. as free ebook thanks to Wellcome) www.bloomsbury.com/uk/rethinkin...

Our Kristin Konnyu is part of a major new £3.8m funded programme, led by researchers at the University of Bath, exploring how to get people more involved in climate action and enable behavioural change. For more information see www.bath.ac.uk/announcement...

Our #DIETRICH trial, looking at the effects of the dietary fibre supplement inulin on key side effects in men receiving radiotherapy for prostate cancer, opened in Aberdeen this week 🎉 The study will open in Manchester and Leeds soon! For more information see w3.abdn.ac.uk/hsru/DIETRIC...

ACE is seeking an experienced researcher to act as Deputy Director (Methodology). The role will provide methodological leadership across CHaRT’s portfolio of clinical trials and related research. For more info and to apply, follow this link: www.abdn.ac.uk/jobs/vacanci...

A huge congratulations to the team at Leeds who have reached their recruitment target for ELIPSE!! @Krish_Narahari, @jonathananing, @Heer_Lab, @vishhanchanale, @benchallacombe, @BURSTurology, @LeedsHospitals

ELIPSE says a huge thank you to the team at Norfolk and Norwich for all their hard work! @Krish_Narahari, @jonathananing, @Heer_Lab, @vishhanchanale, @benchallacombe, @BURSTurology, @NNUH

Milestone achieved! We’ve recruited our 100th participant to the EVEREST study! Huge thanks to the amazing team at Wrightington, Wigan and Leigh Teaching Hospitals NHS FT for recruiting both our 1st and 100th participant, amazing work! 👏 #CHaRTtria @dana_dawson16 @WWL_Research

EVEREST Study in the news -Every participant in a clinical trial helps change the future of healthcare. A huge thank you to all our participants- your involvement truly makes a difference  #EVERESTTrial #Takotsubo #CHaRTtrials @NHSGrampian @dana_dawson16 @NIHRresearch

As part of #MentalHealthAwarenessWeek, we’ve done desk-based stretches and a mini-meditation - thanks to Iwona and Maria and all who participated 😊. Still to come – lunch on #WellbeingWednesday and #FinePieceFriday.

We currently have a vacancy for an Advanced or Senior Research Fellow within the Knowledge Synthesis team (closing date 26 March). Come and join our friendly team! bit.ly/4rLxm6o

BMJ not yet prepared to retract this trial bit.ly/4jBjyIA bit.ly/4aLeQ8L Despite innumerable integrity issues, including repeating patterns of outcome data, see comment #16: bit.ly/3NxsSks

Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)

Objective To assess the effect of intracoronary infusion of mesenchymal stem cells on the development of post-myocardial infarction heart failure. Design Phase 3 randomised clinical trial. Setting T...

bit.ly

A brilliant turnout from our students and staff last week for the MRC NIHR- TMRP DTP annual symposium! We’re excited to welcome newcomer , Malavika Acharya, bringing social-science perspective into evaluating online crowdsourcing for public involvement in trials.

Every year the ACE Social Committee organised the Instant Neighbour Giving Tree which provides new toys & gifts to children across the City & Shire who otherwise would not receive a present at Christmas. We sent 15 gifts for the Giving tree this year, hope it will create more smiles🧒👶 🎁🎄🤶

We would like to express big congratulations @s-greenwood.bsky.social 🥳for passing her PhD viva yesterday. We wish all the best for her bright career ahead. Here's a pic of her post viva celebratory drinks🎉🎉

1/2 Have you seen the letter just published in the Lancet co-authored by our Alison Avenell? www.thelancet.com/journals/lan...

Research integrity is undoubtedly in crisis

Richard Horton's view that there is not a research integrity crisis1 contradicts the initiation of the Lancet Commission on Research Integrity, which states “There is clearly a crisis in research inte...

thelancet.com

Great to see the work of our team (done in collaboration with @nhsgrampian.bsky.social ) referenced extensively in the Scottish Govt Ethnic and Racialised Inequalities in Cancer Services Evidence Review published today. See: www.gov.scot/publications...

Ethnic and Racialised Inequalities in Cancer Services: an Evidence Review

This report summarises the findings of an evidence review into ethnic and racialised inequalities in cancer screening, diagnosis, treatment, care and experience.

gov.scot

@vishhanchanale.bsky.social; @benchallacombe.bsky.social @jimcatto.bsky.social; @bursturology.bsky.social @akoupparis.bsky.social

Check out the newest from our own Kristin Konnyu, "Identifying behaviour change techniques within precision health interventions that use continuous glucose monitoring: a secondary analysis of a scoping review". More info and link to the paper are here: www.linkedin.com/feed/update/...

CGM data is the spark. The real work is what happens next. ——— Our latest CGM paper backs up what I wrote last time: people don’t want raw numbers. They want help turning trends into better choices.… ...

CGM data is the spark. The real work is what happens next. ——— Our latest CGM paper backs up what I wrote last time: people don’t want raw numbers. They want help turning trends into better choices. ...

linkedin.com

Are you someone living with or beyond cancer? Researchers at the University of Aberdeen are inviting you to participate in a questionnaire about taking care of your health. More info and questionnaire here: iahs.qualtrics.com/jfe/form/SV_...

Thrilled to welcome @nhslothian.bsky.social & @Jubilee Hospital to the @nihr.bsky.social funded EVEREST trial team! Exciting times ahead as we explore new frontiers in takotsubo research ⛰️#Research #EVERESTTrial #Takotsubo #CHaRTtrials @Dana Dawson

Happy birthday #ELIPSE! 🥳🎂 Heer Lab, Vishwanath Hanchanale, Krishna Narahari @benchallacombe.bsky.social @jimcatto.bsky.social @bursturology.bsky.social

It’s the Edinburgh Clinical Trial Management Course next month. Great educational opportunity for those involved or interested in trial management. Supported by our own Shaun Treweek and CHaRT trial managers Kirsteen, Lynda, Suzanne and Seonaidh. clinical-research-facility.ed.ac.uk/edinburgh-cl...

We’re delighted to welcome @WWLNHS to the @NIHRresearch funded EVEREST Trial team! 🏔️Excited to work together on this important study. #Research #EVERESTTrial #Takotsubo #CHaRTtrials

🎉🎉Pleased to announce new publication in Translational Behavioral Medicine, our Kristin Konnyu is a co-author : Using the behavior change technique ontology to characterize the content of implementation strategies: A secondary analysis of 151 trials doi.org/10.1093/tbm/...

Using the behavior change technique ontology to characterize the content of implementation strategies: a secondary analysis of 151 trials targeting evidence-based nursing practice

AbstractBackground. Implementation strategies are essential for translating evidence into routine clinical practice. Their effectiveness depends on specify

doi.org

🏔️We’ve reached Base Camp! Recruitment for the @nihr.bsky.social funded EVEREST Trial is officially a go 🚦 1st Green Light issued. Here’s to scaling new heights in Takotsubo research. #EVERESTTrial #Takotsubo #CHaRTtrials @nhsgrampian.bsky.social @dana_dawson16

(1/2) Our Kristin Konnyu is part of one of the strand of the £11.5M @ukri.org funded Transforming Global Evidence project- Methods Work Package. The work will focus on methods development to create AI enhanced 'living #evidencesyntheses ' to inform policymakers the best evidence, more efficient.

From 1st Jan 2026, the journal Trials will mandate reporting of (at least) six participant characteristics for both protocols and reports of trial results. Read more in the editorial: trialsjournal.biomedcentral.com/articles/10.... @ukcrc-ctu.org.uk @ecrin.bsky.social

Who is in your trial? Improving the reporting of participant characteristics in trial protocols and results - Trials

trialsjournal.biomedcentral.com